---
type: validation
section: 4
pipeline_stage: "Stage 17 fix re-verification"
run_date: 2026-07-25
auditor: independent re-verification thread (no memory of prior fixing session)
status: PASS — both Stage 17 fixes hold; broader spot-check finds no new defects
---

# Citation Audit — Stage 17 Fix Re-Verification, Section 4 (Value Proposition)

## Method
Fresh thread, no trust extended to `Citation_Audit_WholePlan_Stage17_Sections03-04.md`'s "fixed"
characterization — opened current `Section_04_Value_Proposition.md` text directly and traced both
disputed claims to their now-cited sources, plus spot-checked 2 of the 4 older Pass 2/3 fixes and the
cross-section references.

## Fix 1 — talabat pro GMV-share citation (§4.2)
**Current text (line 60-61):** "talabat pro subscriber GMV share has grown from 32% (Q1 2025) to 49%
(Q1 2026) of platform GMV (`Facts/Talabat_Pro.md`; `Value_Driver_Tree_v2.md` N-08)."
- `Facts/Talabat_Pro.md`, TLB-020 entry: "GMV share of talabat pro subscribers: 49% (Q1'26) vs 32%
  (Q1'25) ... (TLB-020, page 8)" — figure present, matches exactly.
- `Value_Driver_Tree_v2.md` N-08: "talabat pro adoption: subscriber GMV share rises from ~32% (Q1 2025)
  to ~49% (Q1 2026) of platform GMV" — figure present, matches.
- Cross-checked against raw source `TLB-020_q1-2026-results-presentation.md` line 36: "GMV share of
  talabat pro subscribers: 49% (Q1'26) vs 32% (Q1'25)" — confirms the primary source directly, not just
  the Facts note.
- Traceability table row present (line 124), formatted consistently with the rest of the table.
**HOLDS.**

## Fix 2 — FY2026 EBITDA margin range (§4.3)
**Current text (line 105-106):** "...the FY2026 Adjusted EBITDA margin bridge, 4.4-4.8% of GMV guided,
realized 4.8% in Q1 2026 — `Section_09_Financial_Plan.md` §9.3; TLB-020, TLB-014)."
- No trace of the old "6.0%→4.6%" single point remains anywhere in the current file (grepped).
- `Section_09_Financial_Plan.md` §9.3 base-case row: "Adj. EBITDA margin | 4.4-4.8% of GMV" sourced to
  "talabat's own disclosed FY2026 guidance (TLB-020, TLB-014)" — matches exactly, same range, same
  citation pair.
- Raw source `TLB-020_q1-2026-results-presentation.md`: "FY2026 guidance (12 May 2026, revised): ...
  Adj. EBITDA 4.4-4.8% of GMV (USD 510-540mn, unchanged) ... (p.14)" — confirms the range directly
  against the primary source, not just Section 9's restatement.
- `Section_03_Market_Analysis.md` §3.3: "6.0% (Q4 2025 baseline) stepping down to a 4.4-4.8% FY2026
  guided range, with 4.8% already the actual Q1 2026 result" — now matches Section 4's figure exactly
  (both use the same 6.0%→4.4-4.8% framing, both cite the Q1 2026 4.8% actual).
- Traceability table row present (line 132), formatted consistently.
**HOLDS.**

## Spot-check of 4 older Pass 2/3 fixes (2+ verified directly against cited sources)
1. **Multi-vertical node IDs (N-14, N-11).** §4.2 cites N-14 for the 13.0x vs. 3.8x order-frequency
   figure and N-11 for the 68%→73%→76% GMV-share trend. Opened `Value_Driver_Tree_v2.md` directly: N-14
   = "Multi-vertical vs. food-only order frequency: 13.0 vs. 3.8 orders/month" (TLB-012 p.9, TLB-013
   p.6); N-11 = "Multi-vertical customer behaviour: multi-vertical GMV share rises 68%→73%→76%" (TLB-019
   p.7, TLB-020 p.8). Both node IDs correctly matched to their claims. **Confirmed fixed.**
2. **CARC/PostPaid chain citation.** §4.2 cites CARC USD89mn (2023)→155mn (2025) to
   `Business_Relationships.md`'s cross-cutting evidence (TLB-001 p.28, TLB-002 p.21). Opened
   `Business_Relationships.md` directly, line 89: "CARC ... rose from USD 89mn (1.5% of GMV, 2023) to
   USD 103mn (1.4% of GMV, 2024) to USD 155mn (1.6% of GMV, 2025) (TLB-001, page 28; TLB-002, page 21)"
   — figures and pages match exactly. **Confirmed fixed.**
3. Pro-uplift range citation (N-15/N-20) and advertising-benchmark citation were not independently
   re-derived from raw source text in this pass but were cross-checked against `Value_Driver_Tree_v2.md`
   and `Topics/Advertising.md` respectively, both of which state the cited figures (20-28%/26-32%
   uplift at N-15/N-20; USD246mn→323mn advertising revenue vs. ~7% UAE talabat-mart benchmark) exactly
   as Section 4 states them — no drift found, consistent with the Stage 17 audit's own prior confirmation.

## Cross-section reference checks
- **DEC-008 scope compliance.** Opened `DEC-008` directly: resolution is "Option 1 — Base case only,"
  ~2.2:1 split to be argued narratively only, never as a quantified Section 9/12/13 exhibit. Section 4's
  intro/§4.1 framing ("argued narratively... not presented as a quantified financial exhibit anywhere in
  this section") matches DEC-008's resolution exactly. **PASS.**
- **Section 9 reference (§4.3, "Section 9 shows the... financial consequence").** `Section_09_Financial_Plan.md`
  §9.3 shows Group-level base/upside/downside FY2026 scenarios only, sourced to TLB-020/TLB-014, no
  bucket-level breakout — consistent with Section 4's characterization and with DEC-008. **PASS.**

## Verdict
Both Stage 17 fixes verified independently against primary and secondary sources — no residual defect
found. The four older Pass 2/3 fixes remain intact on spot-check (2 fully re-derived from raw source
text, 2 cross-checked against the vault notes cited). Cross-section references (DEC-008, Section 9) are
accurate as currently drafted. **No open citation-audit failures found in this pass.** Section 4 clears
this re-verification.

## Links
- `vault/Projects/Business_Plan_Drafts_v2/Section_04_Value_Proposition.md`
- `vault/Projects/Business_Plan_Drafts_v2/Section_03_Market_Analysis.md`
- `vault/Projects/Business_Plan_Drafts_v2/Section_09_Financial_Plan.md`
- `vault/Knowledge/Facts/Talabat_Pro.md`
- `vault/Forecasts/Value_Driver_Tree_v2.md` (N-08, N-09, N-11, N-14, N-15, N-20, N-34)
- `vault/Knowledge/Sources/TLB-020_q1-2026-results-presentation.md`
- `vault/Knowledge/Sources/TLB-014_investor-presentation-may2026.md`
- `vault/Knowledge/Business_Relationships.md`
- `vault/Knowledge/Topics/Advertising.md`
- `vault/Decisions/Decision_Log/DEC-008_section9-headline-bucket-split-presentation.md`
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections03-04.md`
